CPT code 87632 is a molecular diagnostic billing code for amplified nucleic acid probe testing that detects multiple respiratory viruses (six to eleven targets), often using multiplex reverse transcription techniques. Nationally, this code is key for reporting comprehensive respiratory pathogen panels used in clinical diagnosis, infection control, and public health surveillance. Its use affects laboratory workflows, coding accuracy, and payer reimbursement for high-complexity molecular testing.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for multiplex respiratory viral testing, common sites of service where CPT code 87632 is billed, and typical billing considerations. The publication summarizes benchmarks and reimbursement patterns, highlights any recent policy updates affecting molecular respiratory panels, and provides guidance on documentation and coding alignment with laboratory reports.

This summary is intended for laboratory managers, coding professionals, and policy analysts seeking concise national-level insights into the clinical and payment landscape for multiplex respiratory viral nucleic acid testing billed under CPT code 87632. Data not available in the input is noted where applicable.